Category: Hims
-
Hims & Hers Health Set to Join S&P SmallCap 600 By Investing.com
•
New York, October 4, 2024 /PRNewswire/ — Hims & Hers Health, Inc. (NYSE:HIMS) will be replaced VICTOR GROUP LIMITED (NYSE:) effective before the opening of trading Wednesday 9 October. GT group acquires Vector set The deal is expected to be closed soon, pending final terms. Below is a summary of…
-
Hims & Hers Health declines as Lilly launches single-dose vials of Zepbound By Investing.com
•
Shares of Hims & Hers Health fell more than 6% Tuesday morning in response to Eli Lilly’s (NYSE:) latest announcement. Lilly announced that it has launched single-dose vials of its obesity drug, Zebound, at a 50% discount to other incretins, a move that comes amid growing competition in the obesity…
-
Hims 85% Wegovy and Ozempic discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
•
Traditional medical practices are getting a boost from new entrants seeking to fill gaps in what health industry executives described Monday as an underdeveloped health care system. That includes Hims & Hers, a direct-to-consumer health company that announced Monday that it will launch a combination version of its weight-loss drugs…